Authors/Disclosures
|
|
No disclosure on file |
|
Kimiaki Utsugisawa, MD, PhD
(Hanamaki General Hospital)
|
Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Utsugisawa has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela Bio. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubisi Tanabe pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Utsugisawa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for argenx. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion phama. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Japan Blood Products Organization. Dr. Utsugisawa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. |
|
Hiroaki Yoshikawa, MD
(Department of Neurology, Kanazawa University)
|
No disclosure on file |
|
Masakatsu Motomura, MD
(Nagasaki University)
|
No disclosure on file |
|
Shiro Matsubara, MD, PhD
(Matsubara Hospital)
|
No disclosure on file |
|
Nicholas W. Wood
(National Hospital for Neuro.)
|
No disclosure on file |
|
Chi-Ying (Roy) Lin, MD, FAAN
(Baylor College of Medicine)
|
Dr. Lin has received research support from Texas Alzheimer's Research and Care Consortium (TARCC). Dr. Lin has received research support from CurePSP. Dr. Lin has received research support from Mike Hogg Fund. Dr. Lin has received research support from The Michael J. Fox Foundation Parkinson's Progression Markers Initiative (PPMI). Dr. Lin has a non-compensated relationship as a Secretary with Broadway for Ataxia Foundation (a 501 (c) (3) non-profit organization) that is relevant to AAN interests or activities. |
|
Kazumasa Yokoyama, MD
|
No disclosure on file |
|
Yuriko Nagane, MD, PhD
(Hanamaki General Hospital, Neurology Dept)
|
No disclosure on file |
|
Takahiro Maruta
|
No disclosure on file |
|
|
No disclosure on file |
|
Norihiro Suzuki
|
No disclosure on file |